Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Hepatology

Building Your Care Team: Finding the Right Specialists

At a Glance

Hepatitis Delta (HDV) is a complex virus that requires a specialized multidisciplinary care team, including a hepatologist, infectious disease specialist, and clinical pharmacist. Preparing your medical records and vetting your doctor's HDV experience are critical steps for optimal care.

Hepatitis Delta (HDV) is a complex, aggressive virus that requires more than just general medical care. Because it is rare and progresses quickly, building a specialized multidisciplinary care team is one of the most important steps you can take to protect your liver health [1][2].

Why You Need a Specialist

While a primary care doctor is essential for your overall health, HDV requires the expertise of a hepatologist (a liver specialist) or an infectious disease (ID) specialist [3][4].

  • Hepatologists: Focus on the health of the liver itself. They are experts in measuring scarring (fibrosis) and monitoring for liver cancer (HCC) [5][6].
  • Infectious Disease Specialists: Focus on the virus. They understand viral replication and the complex interactions between Hepatitis B and Delta [7].
  • Clinical Pharmacists: These team members are vital for managing your medications. They ensure your HBV and HDV drugs don’t interact with other medicines and help you stay on track with your daily or weekly doses [8][9].

Preparing Your “Liver Portfolio”

Specialists can make better decisions when they see the full “story” of your health. Before your first visit, gather the following “physical artifacts” or records:

  • HBsAg History: Records showing how long you have had Hepatitis B and your current “surface antigen” levels [10].
  • HDV RNA Results: All past tests showing your HDV viral load. This helps the doctor see if the virus is stable or increasing [11][6].
  • Liver Enzyme Trends: A history of your ALT and AST levels, which indicate liver inflammation [5].
  • Imaging Reports: Copies of any past ultrasounds, CT scans, or FibroScan results [5][6].
  • Biopsy Results: If you have ever had a liver biopsy, the written pathology report is critical [5].

Vetting Your Doctor

Not all liver specialists have experience with Hepatitis Delta because it is less common than other forms of hepatitis. You have the right to “interview” your doctor to ensure they have the specific knowledge you need. Consider asking:

  1. Experience: “How many patients with HDV have you treated in the last year?” [12]
  2. Current Knowledge: “Are you familiar with the dosing and monitoring requirements for modern HDV treatments like Bulevirtide?” [13]
  3. Research Access: “Does your center offer access to Phase 3 clinical trials for emerging HDV treatments?” [14]

Your First Visit Checklist

To get the most out of your first appointment, follow these steps:

  • [ ] Bring a Support Person: A friend or family member can help take notes and remember details.
  • [ ] Log Your Medications: Include doses for everything you take, including supplements and vitamins [8].
  • [ ] Define Your Goals: Be clear about whether your priority is starting a new treatment, managing symptoms like fatigue, or getting a clearer picture of your liver scarring [15].
  • [ ] Request a Summary: Ask for a printed copy of the doctor’s notes or “after-visit summary” to share with your other care team members.

Having the right experts in your corner ensures that you aren’t just reacting to the virus, but are proactively managing it with the latest medical tools available [16][17].

Common questions in this guide

What kind of doctor treats Hepatitis Delta?
Hepatitis Delta is best managed by a hepatologist (liver specialist) or an infectious disease specialist. These doctors have the specific expertise needed to monitor liver health, manage viral loads, and prescribe targeted treatments.
What medical records should I bring to my first liver specialist appointment?
You should bring a complete 'liver portfolio' to your first visit. This includes your Hepatitis B history, past HDV RNA viral load tests, liver enzyme trends like ALT and AST, imaging reports, and any liver biopsy results.
How do I know if my doctor has enough experience with Hepatitis Delta?
Because Hepatitis Delta is rare, it is important to ask your doctor directly about their experience. You can ask how many HDV patients they have treated recently, their familiarity with modern treatments like Bulevirtide, and if they have access to clinical trials.
What role does a clinical pharmacist play in my HDV care team?
A clinical pharmacist helps manage your medications and ensures your Hepatitis B and Delta drugs do not interact with other medicines or supplements you are taking. They also help you stay on track with complex daily or weekly dosing schedules.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Hepatitis Delta are currently under your care?
  2. 2.What is your experience with prescribing Bulevirtide or other specialized HDV therapies?
  3. 3.Does this clinic participate in clinical trials for new HDV treatments like Lonafarnib or NAPs?
  4. 4.How do you coordinate care between your office and other specialists, like my infectious disease doctor or pharmacist?
  5. 5.What specific 'target' or 'endpoint' are we aiming for in my treatment (e.g., undetectable HDV RNA or normalization of ALT)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    The changing context of hepatitis D.

    Rizzetto M, Hamid S, Negro F

    Journal of hepatology 2021; (74(5)):1200-1211 doi:10.1016/j.jhep.2021.01.014.

    PMID: 33484770
  2. 2

    New actors come into play against hepatitis delta.

    Riveiro-Barciela M, Palom A, Buti M

    Revista espanola de enfermedades digestivas 2022; (114(12)):702-704 doi:10.17235/reed.2022.9050/2022.

    PMID: 36043543
  3. 3

    Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV.

    Anolli MP, Uceda Renteria S, Degasperi E, et al.

    JHEP reports : innovation in hepatology 2025; (7(3)):101299 doi:10.1016/j.jhepr.2024.101299.

    PMID: 40051411
  4. 4

    Is hepatitis delta underestimated?

    Papatheodoridi M, Papatheodoridis GV

    Liver international : official journal of the International Association for the Study of the Liver 2021; (41 Suppl 1()):38-44 doi:10.1111/liv.14833.

    PMID: 34155795
  5. 5

    [Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis].

    Bogomolov PO, Ivashkin VT, Bueverov AO, et al.

    Terapevticheskii arkhiv 2021; (93(11)):1290-1299 doi:10.26442/00403660.2021.11.201163.

    PMID: 36286651
  6. 6

    HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers.

    Roade L, Riveiro-Barciela M, Pfefferkorn M, et al.

    JHEP reports : innovation in hepatology 2023; (5(10)):100842 doi:10.1016/j.jhepr.2023.100842.

    PMID: 37745192
  7. 7

    Triple Threat: HDV, HBV, HIV Coinfection.

    Yen DW, Soriano V, Barreiro P, Sherman KE

    Clinics in liver disease 2023; (27(4)):955-972 doi:10.1016/j.cld.2023.05.010.

    PMID: 37778779
  8. 8

    The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis.

    Ruiz-Ramos J, Hernández MH, Juanes-Borrego AM, et al.

    Journal of the American Medical Directors Association 2021; (22(12)):2518-2526 doi:10.1016/j.jamda.2021.05.038.

    PMID: 34228962
  9. 9

    Patient satisfaction survey of the "Healthy Heart" pharmaceutical care service - evaluation of pharmacy labelling with pharmaceutical pictograms.

    Merks P, Religioni U, Jaguszewski M, et al.

    BMC health services research 2023; (23(1)):962 doi:10.1186/s12913-023-09986-4.

    PMID: 37679680
  10. 10

    Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments.

    Shekhtman L, Duehren S, Etzion O, et al.

    Current gastroenterology reports 2023; (25(12)):401-412 doi:10.1007/s11894-023-00901-9.

    PMID: 37819559
  11. 11

    Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.

    Ricco G, Popa DC, Cavallone D, et al.

    Journal of viral hepatitis 2018; (25(8)):911-919 doi:10.1111/jvh.12895.

    PMID: 29577518
  12. 12

    Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.

    Soriano V, Moreno-Torres V, Treviño A, et al.

    Drug design, development and therapy 2023; (17()):155-166 doi:10.2147/DDDT.S379964.

    PMID: 36712949
  13. 13

    [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment].

    Loureiro D, Castelnau C, Bed CM, Asselah T

    La Revue de medecine interne 2022; (43(3)):160-169 doi:10.1016/j.revmed.2021.10.329.

    PMID: 34799189
  14. 14

    Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.

    Deterding K, Wedemeyer H

    AIDS reviews 2019; (21(3)):126-134 doi:10.24875/AIDSRev.19000080.

    PMID: 31532397
  15. 15

    Viral Hepatitis Other than A, B, and C: Evaluation and Management.

    Cheung A, Kwo P

    Clinics in liver disease 2020; (24(3)):405-419 doi:10.1016/j.cld.2020.04.008.

    PMID: 32620280
  16. 16

    Perceptions and Attitudes Towards Clinical Pharmacy Services and Their Impact on The Management of Cancer in Taif, Saudi Arabia.

    Kabel AM, Bakr MM, Alshanbari AM, et al.

    Asian Pacific journal of cancer prevention : APJCP 2020; (21(2)):531-538 doi:10.31557/APJCP.2020.21.2.531.

    PMID: 32102535
  17. 17

    Federal Bureau of Prisons clinical pharmacy program improves patient A1C.

    Bingham JT, Mallette JJ

    Journal of the American Pharmacists Association : JAPhA 2016; (56(2)):173-7.

    PMID: 27000168

This guide to building a Hepatitis Delta care team is for informational purposes only. Always consult with your primary care provider and liver specialists to determine the best medical care and treatment plan for your specific situation.

Get notified when new evidence is published on Hepatitis delta.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.